vs
Cellyan Biotechnology Co., Ltd（HKPD）与如新（NUS）财务数据对比。点击上方公司名可切换其他公司
如新企业集团是一家美国多层次直销企业，主打研发并销售个人护理产品与营养膳食补充产品，旗下拥有Nu Skin及Pharmanex两大品牌，目前已在全球54个市场开展业务，依托约120万独立销售代表的销售网络覆盖全球市场。
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收
HKPD
NUS
| Q4 25 | — | $370.3M | ||
| Q3 25 | — | $364.2M | ||
| Q2 25 | — | $386.1M | ||
| Q1 25 | — | $364.5M | ||
| Q4 24 | — | $445.6M | ||
| Q3 24 | — | $430.1M | ||
| Q2 24 | — | $439.1M | ||
| Q1 24 | — | $417.3M |
净利润HKPDNUS
| Q4 25 | — | $14.5M | ||
| Q3 25 | — | $17.1M | ||
| Q2 25 | — | $21.1M | ||
| Q1 25 | — | $107.5M | ||
| Q4 24 | — | $-36.1M | ||
| Q3 24 | — | $8.3M | ||
| Q2 24 | — | $-118.3M | ||
| Q1 24 | — | $-533.0K |
毛利率HKPDNUS
| Q4 25 | — | 70.7% | ||
| Q3 25 | — | 70.5% | ||
| Q2 25 | — | 68.8% | ||
| Q1 25 | — | 67.8% | ||
| Q4 24 | — | 62.7% | ||
| Q3 24 | — | 70.1% | ||
| Q2 24 | — | 70.0% | ||
| Q1 24 | — | 70.5% |
营业利润率HKPDNUS
| Q4 25 | — | 6.3% | ||
| Q3 25 | — | 5.9% | ||
| Q2 25 | — | 8.0% | ||
| Q1 25 | — | -2.7% | ||
| Q4 24 | — | -11.9% | ||
| Q3 24 | — | 4.2% | ||
| Q2 24 | — | -28.6% | ||
| Q1 24 | — | 2.1% |
净利率HKPDNUS
| Q4 25 | — | 3.9% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 5.5% | ||
| Q1 25 | — | 29.5% | ||
| Q4 24 | — | -8.1% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | -26.9% | ||
| Q1 24 | — | -0.1% |
每股收益（稀释后）HKPDNUS
| Q4 25 | — | $0.27 | ||
| Q3 25 | — | $0.34 | ||
| Q2 25 | — | $0.43 | ||
| Q1 25 | — | $2.14 | ||
| Q4 24 | — | $-0.73 | ||
| Q3 24 | — | $0.17 | ||
| Q2 24 | — | $-2.38 | ||
| Q1 24 | — | $-0.01 |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
